Budding, K., Bos, J. W., Dijkxhoorn, K., de Zeeuw, E., Bloemenkamp, L. M., Zekveld, E. M., . . . van der Pol, W. L. (2024). IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset. Journal of neuroinflammation, 21(1), 100-14. https://doi.org/10.1186/s12974-024-03090-y
Citácia podle Chicago (17th ed.)Budding, Kevin, et al. "IgM Anti-GM2 Antibodies in Patients with Multifocal Motor Neuropathy Target Schwann Cells and Are Associated with Early Onset." Journal of Neuroinflammation 21, no. 1 (2024): 100-14. https://doi.org/10.1186/s12974-024-03090-y.
Citácia podľa MLA (8th ed.)Budding, Kevin, et al. "IgM Anti-GM2 Antibodies in Patients with Multifocal Motor Neuropathy Target Schwann Cells and Are Associated with Early Onset." Journal of Neuroinflammation, vol. 21, no. 1, 2024, pp. 100-14, https://doi.org/10.1186/s12974-024-03090-y.